The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Novartis Ireland Limited naming David Cullinane .

Filed returns
11
match these filters
Matching filed returns per period 0 1 2 3 5 May–Aug 2021: 1 filed returns May–Aug 2023: 1 filed returns Jan–Apr 2024: 1 filed returns May–Aug 2024: 2 filed returns Sep–Dec 2024: 1 filed returns Jan–Apr 2026: 3 filed returns May–Aug 2026: 2 filed returns 2024 2026
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
May–Aug 2026 Novartis Ireland Limited Health National Cardiovascular Health Strategy (Public policy or programme) 5 On lobbying.ie
May–Aug 2026 Novartis Ireland Limited Health Valuing Innovation & Advanced Cancer Therapy - policy and access (Public policy or programme) 27 On lobbying.ie
Jan–Apr 2026 Novartis Ireland Limited Health Supporting a Health Policy Partnership Initiative for them to run a roundtable and draft a white paper with policy stakeholders. (Public policy or programme) 26 On lobbying.ie
Jan–Apr 2026 Novartis Ireland Limited Health Roundtable policy meeting to discuss EU and Irish Cardiovascular Strategy (Public policy or programme) 5 On lobbying.ie
Jan–Apr 2026 Novartis Ireland Limited Health Implementation of the decision to include SMA in newborn screening (Matters involving public funds) 10 On lobbying.ie
Sep–Dec 2024 Novartis Ireland Limited Health Life Sciences strategy for Ireland (Public policy or programme) 9 On lobbying.ie
May–Aug 2024 Novartis Ireland Limited Health To fund an Office of Life Sciences or Life Science Strategy (Matters involving public funds) 1 On lobbying.ie
May–Aug 2024 Novartis Ireland Limited Health Newborn screening for spinal muscular atrophy (SMA) is implemented for babies in Ireland (Matters involving public funds) 25 On lobbying.ie
Jan–Apr 2024 Novartis Ireland Limited Health Ensure that the healthcare system is ready for new novel treatments like radioligand therapies. Also employing guideline-directed therapy for heart failure patients. (Matters involving public funds) 2 On lobbying.ie
May–Aug 2023 Novartis Ireland Limited Health Ensuring the spinal muscular atrophy (SMA) is added to the heel prick test in a timely manner (Matters involving public funds) 11 On lobbying.ie
May–Aug 2021 Novartis Ireland Limited Health New born screening, timely access to new medicines in Ireland (Public policy or programme) 1 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 11 100.0%